Deval Patel
Emergency Medicine · Atlanta, GANPI 1477768513
Payments from drug & device makers
Across 18 payments — averaging $40.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$143
- Stryker$137
- Gilead$120
- Amgen$96
- Johnson & Johnson$73
- Biofire Diagnostics, LLC$40
- plus $122 from 6 others
What the payments were for
- Speaking & faculty fees$405%
- Food & beverage$69195%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 1 | $143 |
| Stryker | 1 | $137 |
| Gilead | 1 | $120 |
| Amgen | 1 | $96 |
| Johnson & Johnson | 6 | $73 |
| Biofire Diagnostics, LLC | 1 | $40 |
| AstraZeneca | 2 | $36 |
| AbbVie | 1 | $28 |
| CSL Behring | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Melinta Therapeutics, LLC | 1 | $12 |
| Medtronic | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$731 in reported general payments places this provider in the 90th percentile of 1,299 emergency medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 31 | $1,026 |
| Prednisone | 61 | $571 |
| CefuroximeCefuroxime Axetil | 20 | $256 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 47 | $197 |
| Ondansetron OdtOndansetron | 28 | $168 |
| Ibuprofen | 35 | $100 |
| Amlodipine Besylate | 14 | $91 |
| Doxycycline Hyclate | 12 | $81 |
| Tramadol Hcl | 38 | $77 |
| Methocarbamol | 27 | $73 |
| Ciprofloxacin Hcl | 22 | $66 |
| Cyclobenzaprine Hcl | 14 | $30 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in Atlanta
- Jonathan RatcliffAtlanta$177K
- Anna YaffeeAtlanta$101K
- Sean SueAtlanta$28K
- Emma SizemoreAtlanta$27K
- Michael CarrAtlanta$12K
- Louis Rolston-CreglerAtlanta$10K
- Manish PatelAtlanta$8K
- Darria GillespieAtlanta$8K
- Joshua GuttmanAtlanta$8K
- Stewart RichardsonAtlanta$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.